New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/13/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. SEDG
8. QQQ
9. TENB
10. AZN

Go back to New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide
Amgen Inc (NASDAQ: AMGN) Delayed: 377.35 -5.12 (1.34%)
Previous Close $382.47    52 Week High $176.85 
Open $386.14    52 Week Low $133.64 
Day High $386.99    P/E 56.83 
Day Low $377.22    EPS $6.64 
Volume 2,291,464       

(NYSE: UCB) Delayed: 35.29 +0.14 (0.40%)
Previous Close $35.15    52 Week High $ 
Open $35.58    52 Week Low $ 
Day High $35.67    P/E N/A 
Day Low $34.91    EPS $ 
Volume 670,752       

UCB Unsponsored ADR (AMEX: UCBJY) Delayed: 119.35 +2.28 (1.95%)
Previous Close $117.07    52 Week High $46.25 
Open $121.61    52 Week Low $32.74 
Day High $121.61    P/E N/A 
Day Low $119.21    EPS $0.00 
Volume 59,276